Search Results - "Temperton, N"

Refine Results
  1. 1

    Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses In Vitro by Smith, S E, Gibson, M S, Wash, R S, Ferrara, F, Wright, E, Temperton, N, Kellam, P, Fife, M

    Published in Journal of Virology (01-12-2013)
    “…OA  Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+…”
    Get full text
    Journal Article
  2. 2

    An optimised method for the production of MERS-CoV spike expressing viral pseudotypes by Grehan, K., Ferrara, F., Temperton, N.

    Published in MethodsX (01-01-2015)
    “…The production and use of pseudotyped viral particles are widely established for many viruses, and applications in the fields of serology and vaccine…”
    Get full text
    Journal Article
  3. 3

    Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 by Marchi, S, Trombetta, C M, Gasparini, R, Temperton, N, Montomoli, E

    Published in Journal of preventive medicine and hygiene (01-03-2017)
    “…Herpes simplex viruses (HSV) are among the most widespread causative agents of human viral infections. HSV-2 is one of the commonest causes of genital disease,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease by Moyes, David L., Martin, Alex, Sawcer, Stephen, Temperton, Nigel, Worthington, Jane, Griffiths, David J., Venables, Patrick J.

    Published in Genomics (San Diego, Calif.) (01-09-2005)
    “…The human endogenous retroviruses HERV-K113 and HERV-K115 are full-length proviruses but unusual in being found in only a proportion of the population. Here,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    DNA vaccines against cytomegalovirus: current progress by Temperton, N.J.

    “…The development of a vaccine for the prevention of primary cytomegalovirus (CMV) infection is a major public health priority. Live attenuated virus,…”
    Get full text
    Book Review Journal Article
  8. 8

    Distinct Mitochondrial and Cytosolic Enzymes Mediate Trypanothione-dependent Peroxide Metabolism in Trypanosoma cruzi by Wilkinson, Shane R., Temperton, Nigel J., Mondragon, Angeles, Kelly, John M.

    Published in The Journal of biological chemistry (17-03-2000)
    “…The American trypanosome Trypanosoma cruzi is exposed to toxic oxygen metabolites that are generated by drug metabolism and immune responses in addition to…”
    Get full text
    Journal Article
  9. 9

    A transgenic mouse with a humanised B cell repertoire mounts an antibody response to influenza infection and vaccination by Murugaiah, V, Watson, S J, Cunliffe, R F, Temperton, N J, Reece, S T, Kellam, P, Tregoning, J S

    Published in The Journal of infectious diseases (24-09-2024)
    “…The development of a universal influenza vaccine likely requires an understanding of previous exposure to influenza virus (through vaccination or infection)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: Adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides by Temperton, Nigel J., Quenelle, Debra C., Lawson, Keirissa M., Zuckerman, Jane N., Kern, Earl R., Griffiths, Paul D., Emery, Vincent C.

    Published in Journal of medical virology (01-05-2003)
    “…A human cytomegalovirus (HCMV) glycoprotein B (gpUL55) DNA vaccine has been evaluated in BALB/c mice. Intramuscular immunization of these mice with pRc/CMV2‐gB…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole by Temperton, Nigel J., Wilkinson, Shane R., Meyer, David J., Kelly, John M.

    Published in Molecular and biochemical parasitology (30-10-1998)
    “…The parasitic protozoan Trypanosoma cruzi is exposed to toxic oxygen metabolites which arise from drug metabolism or immune mechanisms, in addition to those…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Cloning of an Fe-superoxide dismutase gene homologue from Trypanosoma cruzi by Temperton, Nigel J., Wilkinson, Shane R., Kelly, John M.

    Published in Molecular and biochemical parasitology (01-02-1996)
    “…Development of new chemotherapeutic agents against Chagas' disease is a major WHO objective. Drugs currently in use, such as nifurtimox, often have serious…”
    Get full text
    Journal Article
  18. 18
  19. 19

    In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses by Su, Ching-Yao, Wang, Shi-Yun, Shie, Jiun-Jie, Jeng, King-Song, Temperton, Nigel J., Fang, Jim-Min, Wong, Chi-Huey, Cheng, Yih-Shyun E.

    Published in Antiviral research (01-09-2008)
    “…For the treatment of influenza virus infections, neuraminidase inhibitors (NAIs) that prevent the release of virus particles have been effective against most…”
    Get full text
    Journal Article
  20. 20

    Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses by Oh, Sawyin, Selleck, Paul, Temperton, Nigel J., Chan, Paul K.S., Capecchi, Barbara, Manavis, Jim, Higgins, Geoff, Burrell, Christopher J., Kok, Tuckweng

    Published in Journal of virological methods (01-05-2009)
    “…Four IgG 1κ monoclonal antibodies (mAbs) against Influenza A/Chicken/Vietnam/8/2004 (H5N1) virus are described. Three of these showed neutralizing activities…”
    Get full text
    Journal Article